About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Trp53inp1tm1Acar
targeted mutation 1, Alice Carrier
MGI:3700974
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Trp53inp1tm1Acar/Trp53inp1tm1Acar involves: 129/Sv * C57BL/6 MGI:3701944


Genotype
MGI:3701944
hm1
Allelic
Composition
Trp53inp1tm1Acar/Trp53inp1tm1Acar
Genetic
Background
involves: 129/Sv * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53inp1tm1Acar mutation (2 available); any Trp53inp1 mutation (21 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• less than 50% of mutants with DSS-induced colitis survive to day 15, while less than 10% mortality is observed in controls

adipose tissue
• increase in fat mass
• supplementation with the anti-oxidant N-acetylcysteine abolishes the increased fat mass
• mice fed a high-fat diet show a higher epididymal fat mass than controls
• mice fed a high-fat diet show higher renal fat mass than controls

growth/size/body
• increase in fat mass
• supplementation with the anti-oxidant N-acetylcysteine abolishes the increased fat mass
• increase in body weight of 5 month old mice
• weight gain in AZO-DSS treated mutants is twice that in controls
• 8 week old mice fed a high-fat diet show a higher body weight gain than wild-type mice, even though food consumption does not differ
• treatment with N-acetylcysteine at the starting of a high-fat diet abolishes body weight difference between mutant and wild-type mice
• high-fat diet induced liver weight is increased compared to controls

liver/biliary system
• high-fat diet induced liver weight is increased compared to controls
• high-fat diet induced steatosis is greater in mutants than in wild-type mice
• treatment with N-acetylcysteine at the starting of a high-fat diet abolishes the hepatic steatosis difference between mutant and wild-type mice

neoplasm
N
• mice observed for up to 2 years do not develop tumors
• in mutant and control mice treated with azoxymethane (AZO) and cycles of dextran sodium sulfate (DSS) ingestion, macroscopic tumors in the colon are observed in ~92% of mutants at 9 weeks, compared to ~61% of controls
• multiplicity is 2-fold higher in mutants
• treatment of mice with either AZO or DSS alone is sufficient to induce tumors in mutants after 7 months, whereas no treated wild-type mice develop tumors

digestive/alimentary system
• after 9 days of DSS treatment, mucosal ulcerations are more severe in mutants
• crypt damage is greater in mutants than in wild-type with induced colitis
• inflammation is exacerbated in mutants with colitis than in diseased wild-type mice
• 3-fold higher higher numbers of cells showing NF kappaB activation are observed in mutants with colitis
• mutant mice are more sensitive to DSS-induced colitis than wild-type

endocrine/exocrine glands
• crypt damage is greater in mutants than in wild-type with induced colitis

immune system
• inflammation is exacerbated in mutants with colitis than in diseased wild-type mice
• 3-fold higher higher numbers of cells showing NF kappaB activation are observed in mutants with colitis
• mutant mice are more sensitive to DSS-induced colitis than wild-type

cellular
• large number of lipid droplets in immortalized MEFs
• upon oxidative stress with hydrogen peroxide treatment, immortalized MEFs show an increase in lipid droplets compared to wild-type MEFs
• treatment of MEFs with the antioxidant NAC results in a reduction in lipid droplets
• treatment of MEFs with a PPAR-gamma inhibitor (GW-9662) prevents lipid droplet accumulation
• mitochondrial mass is higher in immortalized MEFs
• increase in the number of mitochondria in immortalized MEFs
• immortalized MEFs exhibit impaired mitophagy of dysfunctional mitochondrial pool
• immortalized MEFs show accumulation of autophagic vacuoles containing mitochondria, indicating a block in late stage of mitophagy
• treatment with hydrogen peroxide has no effect on autophagic vacuole accumulation
• increase in mitochondrial reactive oxygen species-producing activity in immortalized MEFs
• mitochondria occupy a smaller surface in hydrogen peroxide-treated immortalized MEFs than in wild-type MEFs, suggesting impaired ability of mitochondria to cope with stress
• analysis of respiratory chain complexes shows decreased activity of complex IV in immortalized MEFs
• mitochondrial oxygen consumption analysis shows decreased oxygen flow in immortalized MEFs, indicating impaired oxidative phosphorylation
• mutants show increased plasma and colon radical-induced oxidative stress vs wild-type (J:118867)
• after colitis-induction, mutant colons produce more free radicals than wild-type and have lower antioxidant ascorbate levels (J:118867)
• increase in mitochondrial reactive oxygen species-producing activity in immortalized MEFs (J:233434)

homeostasis/metabolism
• immortalized MEFs exhibit impaired mitophagy of dysfunctional mitochondrial pool
• immortalized MEFs show accumulation of autophagic vacuoles containing mitochondria, indicating a block in late stage of mitophagy
• treatment with hydrogen peroxide has no effect on autophagic vacuole accumulation
• 8 week old mice fed a high-fat diet show a higher body weight gain than wild-type mice, even though food consumption does not differ
• treatment with N-acetylcysteine at the starting of a high-fat diet abolishes body weight difference between mutant and wild-type mice
• mice fed a high-fat diet develop hyperglycemia
• however, mice fed a standard diet are not hyperglycemic
• mice fed a high-fat diet exhibit greater hyperinsulinemia than wild-type mice
• however, mice fed a standard diet are not hyperinsulinemic
• mice fed a standard diet are glucose intolerant
• mice fed a high-fat diet show further development of glucose intolerance
• mice fed a standard diet are insulin resistant
• mice fed a high-fat diet show further development of insulin resistance
• less than 50% of mutants with DSS-induced colitis survive to day 15, while less than 10% mortality is observed in controls
• in mutant and control mice treated with azoxymethane (AZO) and cycles of dextran sodium sulfate (DSS) ingestion, macroscopic tumors in the colon are observed in ~92% of mutants at 9 weeks, compared to ~61% of controls
• multiplicity is 2-fold higher in mutants
• treatment of mice with either AZO or DSS alone is sufficient to induce tumors in mutants after 7 months, whereas no treated wild-type mice develop tumors

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
abdominal obesity-metabolic syndrome 1 DOID:14221 OMIM:605552
J:233434





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory